SKOKIE, IL -- (Marketwire) -- 01/05/09 -- NanoInk, Inc., a global leader in nanotechnology, began the new year by announcing the launch of its NanoStem Cell division. The new division will provide a highly reliable, renewable source of differentiated adult stem cells, through the application of proprietary nanopatterning, Dip Pen Nanolithography® technology.

Dr. Haris Jamil, NanoInk's Vice President, Stem Cell Research, is heading up the new division. He expressed high expectations, saying, "I am very excited about our progress in this enormously promising area of scientific research. We will be able to control differentiation of adult stem cells, by using Dip Pen Nanolithography® technology. As a result, we will be able to provide pharmaceutical and biotech companies with access to a large, renewable source of homogeneous stem cells -- an invaluable aid in component screening, toxicity testing, lead candidate validation, and avoiding adverse outcomes in later stages of development."

Recent studies have shown that only 30 percent of drug candidate compounds fail because of poor efficacy, but over 60 percent fail because of toxicity. This is the fundamental cause of the current high attrition rates in drug development. James M. Hussey, NanoInk CEO, commented, "NanoInk now has solutions to the problems that have limited the utility of adult stem cells. Our technology will lead to faster and more efficient drug discovery and development processes, with substantial cost savings." Looking ahead, he added, "In addition, this technology will offer opportunities in clinical diagnostics and will represent a giant step toward delivering on the promise of regenerative medicine."

About NanoInk

NanoInk, Inc. is an emerging growth technology company specializing in nanometer-scale manufacturing and applications development for the life science and semiconductor industries. Using Dip Pen Nanolithography®, a patented and proprietary nanofabrication technology, scientists are enabled to rapidly and easily create nanoscale structures from a wide variety of materials. This low cost, easy to use and scalable technique brings sophisticated nanofabrication to the laboratory desktop. Located in the new Illinois Science + Technology Park, north of Chicago, NanoInk currently has over 140 patents and applications filed worldwide and has licensing agreements with Northwestern University, Stanford University, University of Strathclyde, University of Liverpool, California Institute of Technology and the University of Illinois at Urbana-Champaign. For more information on products and services offered by NanoInk, Inc., see www.nanoink.net.